The diminishing role of surgery in pleural disease

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 4, 2011, Pages 247-254

  Davies, Helen E ^a   Rosenstengel, Andrew ^b   Lee, Y C Gary ^c,d  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

pleural disease; surgery; thoracoscopy

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; BLEOMYCIN; DEOXYRIBONUCLEASE; DOXYCYCLINE; FIBRINOLYTIC AGENT; POVIDONE IODINE; STREPTOKINASE; TALC; TETRACYCLINE; TISSUE PLASMINOGEN ACTIVATOR;

ACUPUNCTURE; ANTIMICROBIAL THERAPY; ATELECTASIS; BLEEDING; BRONCHOPLEURAL FISTULA; CHILDHOOD DISEASE; CHYLOTHORAX; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; DECORTICATION; DEEP VEIN THROMBOSIS; DIET THERAPY; EMPHYSEMA; EMPYEMA; FOLLOW UP; GENERAL ANESTHESIA; GOLD STANDARD; HEALTH CARE COST; HEART ARREST; HEART ARRHYTHMIA; HEART INFARCTION; HOSPITALIZATION; HUMAN; INDWELLING PLEURAL CATHETER; INFECTION RATE; INTUBATION; KIDNEY FAILURE; LENGTH OF STAY; LUNG EMBOLISM; LUNG FUNCTION; LUNG RESECTION; META ANALYSIS (TOPIC); MINIMALLY INVASIVE PROCEDURE; MINIMALLY INVASIVE SURGERY; MORTALITY; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; NERVE BLOCK; OVERALL SURVIVAL; OXYGEN THERAPY; PATIENT SAFETY; PERCUTANEOUS THORACIC DUCT EMBOLIZATION; PLEURA BIOPSY; PLEURA DISEASE; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PLEURECTOMY; PLEURISY; PLEURODESIS; PLEUROSCOPY; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; REPEAT PROCEDURE; RESPIRATORY FAILURE; REVIEW; SEDATION; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL; THORACIC DUCT; THORACOSCOPY; THORACOTOMY; THORAX DRAINAGE; TUBE; VIDEO ASSISTED THORACOSCOPIC SURGERY;

HUMANS; PLEURAL DISEASES; THORACIC SURGICAL PROCEDURES;

EID: 79958776866     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3283474121     Document Type: Review

References (93)

1. Light RW. Pleural diseases. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
2. Clagett OT, Geraci JE. A procedure for the management of postpneumonectomy empyema. J Thorac Cardiovasc Surg 1963; 45:141-145.
3. Rahman NM, Ali NJ, Brown G, et al. Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl 2):ii54-ii60.
4. Furrer M, Rechsteiner R, Eigenmann V, et al. Thoracotomy and thoracoscopy: postoperative pulmonary function, pain and chest wall complaints. Eur J Cardiothorac Surg 1997; 12:82-87. (Pubitemid 27321878)
5. Dajczman E, Gordon A, Kreisman H, Wolkove N. Long-term postthoracotomy pain. Chest 1991; 99:270-274.
6. Blanc FX, Atassi K, Bignon J, Housset B. Diagnostic value of medical thoracoscopy in pleural disease: a 6-year retrospective study. Chest 2002; 121:1677-1683. (Pubitemid 34499687)
7. Boutin C, Rey F. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 1: Diagnosis. Cancer 1993; 72:389-393. (Pubitemid 23193443)
8. Davidson AC, George RJ, Sheldon CD, et al. Thoracoscopy: assessment of a physician service and comparison of a flexible bronchoscope used as a thoracoscope with a rigid thoracoscope. Thorax 1988; 43:327-332.
9. Debeljak A, Kecelj P. Medical thoracoscopy: experience with 212 patients. J Buon 2000; 5:169-172. (Pubitemid 30618080)
10. Fielding D, Hopkins P, Serisier D. Frozen section of pleural biopsies at medical thoracoscopy assists in correctly identifying benign disease. Respirology 2005; 10:636-642. (Pubitemid 44944461)
11. Fletcher SV, Clark RJ. The Portsmouth thoracoscopy experience: an evaluation of service by retrospective case note analysis. Respir Med 2007; 101:1021-1025. (Pubitemid 46505984)
12. Hansen M, Faurschou P, Clementsen P. Medical thoracoscopy, results and complications in 146 patients: a retrospective study. Respir Med 1998; 92:228-232. (Pubitemid 28116244)
13. Janssen JP, Ramlal S, Mravunac M. The long-term follow up of exudative pleural effusion after nondiagnostic thoracoscopy. J Bronchol 2004; 11:169-174. (Pubitemid 39031222)
14. Lee P, Hsu A, Lo C, Colt HG. Prospective evaluation of flex-rigid pleuroscopy for indeterminate pleural effusion: accuracy, safety and outcome. Respirology 2007; 12:881-886. (Pubitemid 350045712)
15. Macha HN, Reichle G, von Zwehl D, et al. The role of ultrasound assisted thoracoscopy in the diagnosis of pleural disease. Clinical experience in 687 cases. Eur J Cardiothorac Surg 1993; 7:19-22.
16. McLean AN, Bicknell SR, McAlpine LG, Peacock AJ. Investigation of pleural effusion: an evaluation of the new Olympus LTF semiflexible thoracofiberscope and comparison with Abram's needle biopsy. Chest 1998; 114:150-153. (Pubitemid 28337376)
17. Menzies R, Charbonneau M. Thoracoscopy for the diagnosis of pleural disease. Ann Intern Med 1991; 114:271-276.
18. Munavvar M, Khan MA, Edwards J, et al. The autoclavable semirigid thoracoscope: the way forward in pleural disease? Eur Respir J 2007; 29:571-574.
19. Oldenburg FA Jr, Newhouse MT. Thoracoscopy. A safe, accurate diagnostic procedure using the rigid thoracoscope and local anesthesia. Chest 1979; 75:45-50.
20. Sakuraba M, Masuda K, Hebisawa A, et al. Diagnostic value of thoracoscopic pleural biopsy for pleurisy under local anaesthesia. ANZ J Surg 2006; 76:722-724. (Pubitemid 44154744)
21. Schwarz C, Lubbert H, Rahn W, et al. Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer. Eur Respir J 2004; 24:728-730. (Pubitemid 39504422)
22. Simpson G. Medical thoracoscopy in an Australian regional hospital. Intern Med J 2007; 37:267-269. (Pubitemid 46457504)
23. Smit HJ, Schramel FM, Sutedja TG, et al. Video-assisted thoracoscopy is feasible under local anesthesia. Diagn Ther Endosc 1998; 4:177-182.
24. Tassi G, Marchetti G. Minithoracoscopy: a less invasive approach to thoracoscopy. Chest 2003; 124:1975-1977. (Pubitemid 37433599)
25. Wilsher ML, Veale AG. Medical thoracoscopy in the diagnosis of unexplained pleural effusion. Respirology 1998; 3:77-80. (Pubitemid 28334583)
26. Waller DA, Hasan A, Forty J, Morritt GN. Videothoracoscopy in the diagnosis of intrathoracic pathology: early experience. Ann R Coll Surg Engl 1994; 76:123-126. (Pubitemid 24070587)
27. Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl 2):ii4-ii17.
28. Loddenkemper R. Thoracoscopy: state of the art. Eur Respir J 1998; 11:213-221.
29. Leung AN, Muller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990; 154:487-492. (Pubitemid 20071594)
30. Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009; 64:139-143.
31. Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008; 102:744-754.
32. Scherpereel A, Lee YC. Biomarkers for mesothelioma. Curr Opin Pulm Med 2007; 13:339-443.
33. Tung A, Porcel JM, Bilaceroglu S, et al. Biomarkers in pleural disease. US Respiratory Diseases 2011 (in press).
34. Davies HE, Sadler RS, Bielsa S, et al. Clinical impact and reliability of pleural fluid mesothelin in undiagnosed pleural effusions. Am J Respir Crit Care Med 2009; 180:437-444.
35. Davies HE, Nicholson JE, Rahman NM, et al. Outcome of patients with nonspecific pleuritis/fibrosis on thoracoscopic pleural biopsies. Eur J Cardiothorac Surg 2010; 38:472-477.
36. Venekamp LN, Velkeniers B, Noppen M. Does 'idiopathic pleuritis' exist? Natural history of nonspecific pleuritis diagnosed after thoracoscopy. Respiration 2005; 72:74-78.
37. Farjah F, Symons RG, Krishnadasan B, et al. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg 2007; 133:346-351.
38. Landreneau RJ, Keenan RJ, Hazelrigg SR, et al. Thoracoscopy for empyema and hemothorax. Chest 1996; 109:18-24. (Pubitemid 26017586)
39. Maskell NA, Davies CW, Nunn AJ, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352:865-874. In this double-blind randomized placebo-controlled trial of 454 patients, no improvement in mortality, rate of surgery or length of hospital stay was shown with the intrapleural administration of streptokinase among patients with pleural infection.
40. MacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl 2):ii18-ii31.
41. Sonnappa S, Cohen G, Owens CM, et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006; 174:221-227. (Pubitemid 44015396)
42. St Peter SD, Tsao K, Spilde TL, et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg 2009; 44:106-111.
43. Bilgin M, Akcali Y, Oguzkaya F. Benefits of early aggressive management of empyema thoracis. ANZ J Surg 2006; 76:120-122. (Pubitemid 43363010)
44. Wait MA, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empyema therapy. Chest 1997; 111:1548-1551. (Pubitemid 27260081)
45. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004:CD002312.
46. Tokuda Y, Matsushima D, Stein GH, Miyagi S. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis. Chest 2006; 129:783-790.
47. Light RW, Nguyen T, Mulligan ME, Sasse SA. The in vitro efficacy of varidase versus streptokinase or urokinase for liquefying thick purulent exudative material from loculated empyema. Lung 2000; 178:13-18. (Pubitemid 30111713)
48. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000; 117:1728-1733. (Pubitemid 30413370)
49. Rahman NM, Maskell NA, Davies CWH, et al. Primary result of the second multicentre intrapleural sepsis (MIST2) trial; randomised trial of intrapleural tPA and DNase in pleural infection [abstract]. Thorax 2009; 64: A1.
50. Davies HE, Davies RJ, Davies CW. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl 2):ii41-ii53.
51. Diacon AH, Theron J, Schuurmans MM, et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004; 170:49-53. (Pubitemid 38997750)
52. Rahman NM, Maskell NA, Davies CW, et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest 2010; 137:536-543. This analysis of patients with pleural infection shows that smaller bore chest tubes cause less pain than larger tubes, inserted using blunt dissection, with no impairment of clinical outcome.
53. Davies HE, Merchant S, McGown A. A study of the complications of small bore 'Seldinger' intercostal chest drains. Respirology 2008; 13:603-607.
54. Clementsen P, Evald T, Grode G, et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med 1998; 92:593-596. (Pubitemid 28162178)
55. Benton IJ, Benfield GF. Comparison of a large and small-calibre tube drain for managing spontaneous pneumothoraces. Respir Med 2009; 103:1436-1440.
56. Parulekar W, Di Primio G, Matzinger F, et al. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest 2001; 120:19-25. (Pubitemid 32744851)
57. Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18:581-592.
58. Marel M, Zrustova M, Stasny B, Light RW. The incidence of pleural effusion in a well defined region. Epidemiologic study in central Bohemia. Chest 1993; 104:1486-1489.
59. Diacon AH, Wyser C, Bolliger CT, et al. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions. Am J Respir Crit Care Med 2000; 162 (4 Pt 1):1445-1449.
60. Fentiman IS, Rubens RD, Hayward JL. A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur J Cancer Clin Oncol 1986; 22:1079-1081. (Pubitemid 16017143)
61. Haddad FJ, Younes RN, Gross JL, Deheinzelin D. Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial. World J Surg 2004; 28:749-753. (Pubitemid 39315388)
62. Hamed H, Fentiman IS, Chaudary MA, Rubens RD. Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br J Surg 1989; 76:1266-1267. (Pubitemid 20026702)
63. Noppen M, Degreve J, Mignolet M, Vincken W. A prospective, randomised study comparing the efficacy of talc slurry and bleomycin in the treatment of malignant pleural effusions. Acta Clin Belg 1997; 52:258-262. (Pubitemid 27528816)
64. Ong KC, Indumathi V, Raghuram J, Ong YY. A comparative study of pleurodesis using talc slurry and bleomycin in the management of malignant pleural effusions. Respirology 2000; 5:99-103. (Pubitemid 30434955)
65. Zimmer PW, Hill M, Casey K, et al. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997; 112:430-434. (Pubitemid 27349435)
66. Genofre EH, Vargas FS, Antonangelo L, et al. Ultrastructural acute features of active remodeling after chemical pleurodesis induced by silver nitrate or talc. Lung 2005; 183:197-207. (Pubitemid 41187521)
67. Idell S, Pendurthi U, Pueblitz S, et al. Tissue factor pathway inhibitor in tetracycline-induced pleuritis in rabbits. Thromb Haemost 1998; 79:649-655. (Pubitemid 28120805)
68. Kennedy L, Harley RA, Sahn SA, Strange C. Talc slurry pleurodesis. Pleural fluid and histologic analysis. Chest 1995; 107:1707-1712.
69. Marchi E, Vargas FS, Acencio MM, et al. Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis. Eur Respir J 2006; 28:929-932. (Pubitemid 46331960)
70. Mager HJ, Maesen B, Verzijlbergen F, Schramel F. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer 2002; 36:77-81. (Pubitemid 34224899)
71. Dresler CM, Olak J, Herndon JE, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005; 127:909-915. In this phase III study of 501 patients, no difference was seen in pleurodesis efficacy between thoracoscopic talc poudrage and talc slurry tube pleurodesis.
72. Mohsen TA, Zeid AA, Meshref M, et al. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial. Eur J Cardiothorac Surg 2010 [Epub ahead of print].
73. Terra RM, Junqueira JJ, Teixeira LR, et al. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis? Chest 2009; 136:361-368.
74. Yim AP, Chan AT, Lee TW, et al. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996; 62:1655-1658. (Pubitemid 26421097)
75. Roberts ME, Neville E, Berrisford RG, et al. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl 2):ii32-ii40.
76. Suzuki K, Servais EL, Rizk NP, et al. Palliation and pleurodesis in malignant pleural effusion: the role for tunnelled pleural catheters. J Thorac Oncol 2011 (in press).
77. Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004; 128:138-146. (Pubitemid 38881208)
78. Rice DC, Stevens CW, Correa AM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007; 84:1685-1692.
79. Stewart DJ, Martin-Ucar AE, Edwards JG, et al. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations. Eur J Cardiothorac Surg 2005; 27:373-378. (Pubitemid 40312340)
80. Hasani A, Alvarez JM, Wyatt JM, et al. Outcome for patients with malignant pleural mesothelioma referred for trimodality therapy in Western Australia. J Thorac Oncol 2009; 4:1010-1016.
81. Schipper PH, Nichols FC, Thomse KM, et al. Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 2008; 85:257-264. (Pubitemid 350265795)
82. Weder W, Stahel RA, Bernhard J, et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007; 18:1196-1202. (Pubitemid 47244366)
83. Treasure T, Tan C, Lang-Lazdunski L, Waller D. The MARS trial: mesothelioma and radical surgery. Interact Cardiovasc Thorac Surg 2006; 5:58-59. (Pubitemid 43200170)
84. Treasure T, Waller D, Tan C, et al. The mesothelioma and radical surgery randomized controlled trial: the Mars feasibility study. J Thorac Oncol 2009; 4:1254-1258.
85. Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008; 135:620-626.
86. Nakas A, Martin Ucar AE, Edwards JG, Waller DA. The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2008; 33:83-88. (Pubitemid 350284603)
87. Flores RM, Zakowski M, Venkatraman E, et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2007; 2:957-965. (Pubitemid 47511601)
88. Cope C, Kaiser LR. Management of unremitting chylothorax by percutaneous embolization and blockage of retroperitoneal lymphatic vessels in 42 patients. J Vasc Interv Radiol 2002; 13:1139-1148. (Pubitemid 35332900)
89. Cope C. Management of chylothorax via percutaneous embolization. Curr Opin Pulm Med 2004; 10:311-314. (Pubitemid 38803126)
90. Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119:590-602. (Pubitemid 32163775)
91. Chee CB, Abisheganaden J, Yeo JK, et al. Persistent air-leak in spontaneous pneumothorax: clinical course and outcome. Respir Med 1998; 92:757-761. (Pubitemid 128717170)
92. Ferraro P, Beauchamp G, Lord F, et al. Spontaneous primary and secondary pneumothorax: a 10-year study of management alternatives. Can J Surg 1994; 37:197-202. (Pubitemid 24246377)
93. Tschopp JM, Brutsche M, Frey JG. Treatment of complicated spontaneous pneumothorax by simple talc pleurodesis under thoracoscopy and local anaesthesia. Thorax 1997; 52:329-332. (Pubitemid 27204893)